DATA: 01/02/2019


The Italian IBD association A.M.I.C.I Onlus and the Italian Group for the study of Inflammatory Bowel Disease have presented the data obtained from a recent survey on knowledge and use of biosimilar drugs. Results show an alarming lack of information about biosimilars drugs. The scientific community and patient organisations deem that an awareness campaign is undelayable in light of the development of the new innovative drugs.

read more